Oxytocin hypersensitivity in pregnant P-LAP deficient mice

Life Sciences

Volumn 84, Issue 19-20, 2009, Pages 668-672

  Ishii, Masakazu ^a   Naruse, Katsuhiko ^b   Hattori, Akira ^c   Tsujimoto, Masafumi ^c   Ishiura, Shoichi ^d   Numaguchi, Yasushi ^a   Murohara, Toyoaki ^e   Kobayashi, Hiroshi ^b   Mizutani, Shigehiko ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c RIKEN   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Arginine vasopressin (AVP); Oxytocin receptor (OTR); Oxytocinase placental leucine aminopeptidase (P LAP); Preterm labor; Vasopressin receptor

Indexed keywords

ARGIPRESSIN; CYTOSOL AMINOPEPTIDASE; OXYTOCIN;

ANIMAL EXPERIMENT; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME DEFICIENCY; FEMALE; GESTATION PERIOD; KNOCKOUT MOUSE; LABOR INDUCTION; LABOR ONSET; MOUSE; NONHUMAN; PREGNANCY; PREMATURE LABOR; URINE VOLUME; WILD TYPE;

ANIMALS; ARGININE VASOPRESSIN; CYSTINYL AMINOPEPTIDASE; FEMALE; LABOR, OBSTETRIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVARY; OXYTOCIN; PREGNANCY; PREGNANCY, ANIMAL; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; UTERUS;

MUS;

EID: 65049084574     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.02.018     Document Type: Article

References (24)

1. Barker D.J., Gluckman P.D., Godfrey K.M., Harding J.E., Owens J.A., and Robinson J.S. Fetal nutrition and cardiovascular disease in adult life. Lancet 341 8850 (1993) 938-941
2. Chard T., Hudson C.N., Edwards C.R., and Boyd N.R. Release of oxytocin and vasopressin by the human foetus during labour. Nature 234 5328 (1971) 352-354
3. Diczfalusy E. Endocrine functions of the human fetoplacental unit. Federation Proceedings 23 (1964) 791-798
4. Einspanier A., Jurdzinski A., and Hodges J.K. A local oxytocin system is part of the luteinization process in the preovulatory follicle of the marmoset monkey (Callithrix jacchus). Biology of Reproduction 57 (1997) 16-26
5. Engstrøm T., Bratholm P., Vilhardt H., and Christensen N.J. Effect of oxytocin receptor and beta2-adrenoceptor blockade on myometrial oxytocin receptors in parturient rats. Biology of Reproduction 60 2 (1999) 322-329
6. Fletcher S.E., Fyfe D.A., Case C.L., Wiles H.B., Upshur J.K., and Newman R.B. Myocardial necrosis in a newborn after long-term maternal subcutaneous terbutaline infusion for suppression of preterm labor. American Journal of Obstetrics and Gynecology 165 5 (1991) 1401-1404
7. Gross G.A., Imamura T., Luedke C., Vogt S.K., Olson L.M., Nelson D.M., Sadovsky Y., and Muglia L.J. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proceedings of the National Academy of Sciences of the United States of America 95 20 (1998) 11875-11879
8. Imamura T., Luedke C.E., Vogt S.K., and Muglia L.J. Oxytocin modulates the onset of murine parturition by competing ovarian and uterine effects. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 279 3 (2000) R1061-R1067
9. Keller S.R., Davis A.C., and Clairmont K.B. Mice deficient in the insulin-regulated membrane aminopeptidase show substantial decreases in glucose transporter GLUT4 levels but maintain normal glucose homeostasis. Journal of Biological Chemistry 277 20 (2002) 17677-17686
10. Kreider M.L., Seidler F.J., and Slotkin T.A. Beta-adrenoceptor modulation of transiently overexpressed alpha 2-adrenoceptors in brain and peripheral tissues: cellular mechanisms underlying the developmental toxicity of terbutaline. Brain Research Bulletin 62 4 (2004) 305-314
11. Matsumoto H., Rogi T., Yamashiro K., Kodama S., Tsuruoka N., Hattori A., Takio K., Mizutani S., and Tsujimoto M. Characterization of a recombinant soluble form of human placental leucine aminopeptidase/oxytocinase expressed in Chinese hamster ovary cells. European Journal of Biochemistry 267 1 (2000) 46-52
12. McCracken J.A., Custer E.E., Lamsa J.C., and Robinson A.G. The central oxytocin pulse generator: a pacemaker for luteolysis. Advances in Experimental Medicine and Biology 395 (1995) 133-154
13. Mitsui T., Nomura S., Okada M., Ohno Y., Kobayashi H., Nakashima Y., Murata Y., Takeuchi M., Kuno N., Nagasaka T., O-Wang J., Cooper M.D., and Mizutani S. Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice. Molecular Medicine 9 1-2 (2003) 57-62
14. Mizutani S., Hayakawa H., Akiyama H., Sakura H., Yoshino M., Oya M., and Kawashima Y. Simultaneous determinations of plasma oxytocin and serum placental leucine aminopeptidase (P-LAP) during late pregnancy. Clinical Biochemistry 15 3 (1982) 141-145
15. Mizutani S., Shibata K., Kikkawa F., Hattori A., Tsujimoto M., Ishii M., and Kobayashi H. Essential role of placental leucine aminopeptidase in gynecologic malignancy. Expert Opinion on Therapeutic Targets 11 4 (2007) 453-461
16. Motta A.B., Franchi A.M., Faletti A., and Gimeno M.F. Effect of an oxytocin receptor antagonist on ovarian and uterine synthesis and release of prostaglandin F2 alpha in pseudopregnant rats. Prostaglandins, Leukotrienes and Essential Fatty Acids 54 2 (1996) 95-100
17. Nishimori K., Young L.J., Guo Q., Wang Z., Insel T.R., and Matzuk M.M. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proceedings of the National Academy of Sciences of the United States of America 93 21 (1996) 11699-11704
18. Oosterbaan H.P., and Swaab D.F. Amniotic oxytocin and vasopressin in relation to human fetal development and labour. Early Human Development 19 4 (1989) 253-262
19. Reversi A., Rimoldi V., Marrocco T., Cassoni P., Bussolati G., Parenti M., and Chini B. The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism. Journal of Biological Chemistry 280 16 (2005) 16311-16318
20. Sheldrick E.L. Effect of continuous infusion of oxytocin on ovarian function and uterine oxytocin receptor concentration in the cyclic ewe. Reproduction, Fertility and Development 4 5 (1992) 505-513
21. Toyo-Oka T., Kawada T., Nakata J., Xie H., Urabe M., Masui F., Ebisawa T., Tezuka A., Iwasawa K., Nakajima T., Uehara Y., Kumagai H., Kostin S., Schaper J., Nakazawa M., and Ozawa K. Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for progression of cardiac dysfunction. Proceedings of the National Academy of Sciences of the United States of America 101 19 (2004) 7381-7385
22. Tsujimoto M., Mizutani S., Adachi H., Kimura M., Nakazato H., and Tomoda Y. Identification of human placental leucine aminopeptidase as oxytocinase. Archives of Biochemistry and Biophysics 292 2 (1992) 388-392
23. Wallis M.G., Lankford M.F., and Keller S.R. Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP. American Journal of Physiology, Endocrinology and Metabolism 293 4 (2007) E1092-E1102
24. Yamahara N., Nomura S., Suzuki T., Itakura A., Ito M., Okamoto T., Tsujimoto M., Nakazato H., and Mizutani S. Placental leucine aminopeptidase/oxytocinase in maternal serum and placenta during normal pregnancy. Life Sciences 66 15 (2000) 1401-1410